½ÃÀ庸°í¼­
»óǰÄÚµå
1600718

Åõ¼®±â ½ÃÀå : À¯Çüº°, ¸· Àç·áº°, Çѿܿ©°ú °è¼öº°, ±¸¼ºº°, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Dialyzer Market by Type, Membrane Material, Ultrafiltration Coefficient, Configuration, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 181 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Åõ¼®±â ½ÃÀåÀº 2023³â¿¡ 119¾ï 8,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, 2024³â¿¡´Â 126¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 5.66%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 176¾ï 2,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Åõ¼®±â ½ÃÀåÀº Ç÷¾×Åõ¼®¿¡ »ç¿ëµÇ´Â Àåºñ·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù. Ç÷¾×Åõ¼®Àº ÁÖ·Î ½ÅºÎÀüÁõ ȯÀÚÀÇ Ç÷¾×¿¡¼­ ³ëÆó¹°°ú °úµµÇÑ ¼öºÐÀ» Á¦°ÅÇÏ´Â °úÁ¤ÀÔ´Ï´Ù. Åõ¼®±â´Â ½ÅÀåÁúȯ °ü¸®¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇϹǷΠÀÇ·á ÇöÀå¿¡¼­ÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ ÀÇ·á±â±âÀÇ ÁÖ¿ä »ç¿ëó´Â º´¿ø ¹× Ŭ¸®´ÐÀ̸ç, Æí¸®ÇÑ ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÔ¿¡ µû¶ó ÃÖÁ¾»ç¿ëÀÚ´Â ¹Î°£ Ä¡·á ¼¾ÅÍ¿Í Àç°¡ ¿ä¾ç¿ø±îÁö È®´ëµÇ°í ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀåÀº ¸¸¼º ½ÅÀåÁúȯÀÇ À¯º´·ü Áõ°¡, ´ç´¢º´ ¹× °íÇ÷¾Ð ȯÀÚ ¼ö Áõ°¡, ȯÀÚÀÇ Æí¾ÈÇÔ°ú Ä¡·á È¿°ú¸¦ Çâ»ó½ÃŰ´Â Åõ¼®±âÀÇ ±â¼ú ¹ßÀü¿¡ Å©°Ô ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ƯÈ÷ ÈÞ´ë¿ë Åõ¼® ½Ã½ºÅÛ°ú ÀçÅà Åõ¼® ½Ã½ºÅÛ¿¡¼­ ÀáÀçÀûÀÎ ºñÁî´Ï½º ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº Ä¡·áºñ, ¾ö°ÝÇÑ ±ÔÁ¦, ÀÇ·áºñ »óȯ Á¤Ã¥¿¡ ´ëÇÑ ÀÇÁ¸¼º µîÀÌ ½ÃÀå ¼ºÀåÀÇ °É¸²µ¹·Î ÀÛ¿ëÇÒ ¼ö ÀÖÀ¸¸ç, ƯÁ¤ Áö¿ª¿¡¼­ÀÇ ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. »ýüÀûÇÕ¼º Àç·á¿Í ¼ÒÇüÈ­ ±â¼úÀ» À§ÇÑ ¿¬±¸°³¹ßÀÌ È°¹ßÈ÷ ÁøÇàµÇ°í ÀÖÀ¸¸ç, ÀÌ´Â ±âÁ¸ Ä¡·áÀÇ Á¦¾à¿äÀÎÀÎ Ç÷°ü Á¢±Ù ÇÕº´Áõ°ú Åõ¼® °ü·Ã °¨¿°À» ÇØ°áÇÏ°í º¸´Ù È¿À²ÀûÀ̰í ȯÀÚ Ä£È­ÀûÀÎ Á¦Ç°À» °³¹ßÇϱâ À§ÇÑ ±â¼ú Çõ½Å¿¡ ¹ÚÂ÷¸¦ °¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °æÀïÀº Ä¡¿­ÇØÁö°í ÀÖÀ¸¸ç, ¾÷üµéÀº ²÷ÀÓ¾øÀÌ ±â¼ú °³¼±À» À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ °¢ ¾÷üµéÀº Àú·ÅÇÑ °¡°Ý´ëÀÇ ¸ðµ¨ Çõ½Å°ú Àü·«Àû Á¦ÈÞ¸¦ ÅëÇØ ½ÃÀå ÁøÀÔÀÇ ÆøÀ» ³ÐÈ÷´Â µ¥ ÁÖ·ÂÇØ¾ß ÇÕ´Ï´Ù. ƯÁ¤ ȯÀÚ ±×·ì¿¡ ¸Â´Â Åõ¼®¸·°ú °°Àº ¸ÂÃãÇü Åõ¼® Ä¡·á¹ýÀÇ °³¹ßÀº ¿©ÀüÈ÷ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ´Â ¿¬±¸°³¹ß ºÐ¾ßÀÔ´Ï´Ù. Çõ½Å°ú È®ÀåÀ» ¿øÇÏ´Â ±â¾÷Àº ÀÇ·á ÀÎÇÁ¶ó ±¸Ãà°ú Àü ¼¼°è ½ÅÀåÁúȯ ºÎ´ã Áõ°¡ÀÇ ±³Â÷Á¡À» ÀÌ¿ëÇÏ¿© Á¦Ç° Á¢±Ù¼º Çâ»ó, Ä¡·á ÃÖÀûÈ­¸¦ À§ÇÑ ÀΰøÁö´É Ȱ¿ë, ¹ÌÃæÁ· Ç÷¾×Åõ¼® ¼ö¿ä°¡ ÀÖ´Â ½ÅÈï ±¹°¡ ½ÃÀå °³Ã´¿¡ ÁýÁßÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ[2023³â] 119¾ï 8,000¸¸ ´Þ·¯
¿¹Ãø³â[2024³â] 126¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â[2030³â] 176¾ï 2,000¸¸ ´Þ·¯
CAGR(%) 5.66%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â Åõ¼®±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®¸¦ °ø°³ÇÕ´Ï´Ù.

Åõ¼®±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ëÀ» ÅëÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¿ªÀû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÅÀå ÀÌ½Ä ºÎÁ·À¸·Î ÀÎÇÑ ´ç´¢º´ ¹× °íÇ÷¾ÐÀÇ À¯Çà
    • °í·ÉÀÚ Áõ°¡¿Í ³ëÈ­¿¡ µû¸¥ ½ÅÀåÁúȯ Áõ°¡
    • Åõ¼® Á¦Ç° °³¼± ¹× °³¹ß ÀÚ±Ý Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Ç÷¾×Åõ¼®¿¡ µû¸¥ ÇÕº´Áõ°ú À§Ç輺
  • ½ÃÀå ±âȸ
    • ½Å±Ô °³¹ß ¹× ½ÂÀÎ Á¦Ç° Áõ°¡¿¡ µû¸¥ äÅ÷ü Çâ»ó
    • ÀçÅà Ç÷¾×Åõ¼® ¼±È£µµ Áõ°¡¿Í ¿þ¾î·¯ºí-ÈÞ´ë¿ë Åõ¼®±â±âÀÇ ÀáÀç·Â
  • ½ÃÀå °úÁ¦
    • ½ÅÀå ´ëü Ä¡·á¹ýÀ» ¼±ÅÃÇϴ ȯÀÚ ¼ö Áõ°¡

Porter's Five Forces: Åõ¼®±â ½ÃÀå °ø·«À» À§ÇÑ Àü·« Åø

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â µ¥ Áß¿äÇÑ ÅøÀÔ´Ï´Ù. PorterÀÇ Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ¸ð»öÇϱâ À§ÇÑ ¸íÈ®ÇÑ ¹æ¹ýÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» º¸¿ÏÇϰí, ÀáÀçÀû µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Åõ¼®±â ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Åõ¼®±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ ´ã°í ÀÖÀ¸¸ç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀ̰í Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : Åõ¼®±â ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

Åõ¼®±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ¼¼ºÐÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÏ¿© °ø±Þ¾÷ü°¡ Ä¡¿­ÇÑ °æÀï¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®À» Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º: Åõ¼®±â ½ÃÀå³» °ø±Þ¾÷üµéÀÇ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Åõ¼®±â ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀº º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ±¸ºÐÇÏ¿© »ç¿ëÀÚ°¡ Àü·«Àû¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. Àü·«Àû¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÎ¹®¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ¾÷°è ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅ͸¦ Æ÷ÇÔÇÑ ÇöÀç ½ÃÀå ȯ°æ¿¡ ´ëÇÑ »ó¼¼ÇÑ °ËÅä.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ±â¼úÇϰí ÀÖ½À´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå Åõ¼®±â ½ÃÀå : À¯Çüº°

  • ¼­·Ð
  • °íÇ÷°½º Åõ¼®±â
  • ÀúÇ÷°½º Åõ¼®±â
  • ´Ü¹éÁú ´©¶ô¸· Åõ¼®±â

Á¦7Àå Åõ¼®±â ½ÃÀå : ¸· Àç·áº°

  • ¼­·Ð
  • ¾Æ¼¼Å×ÀÌÆ® ¼¿·ê·Î¿À½º¸· Åõ¼®±â
  • Àç»ý ¼¿·ê·Î¿À½º¸· Åõ¼®±â
  • ¼¶À¯ ¸âºê·¹ÀÎ ±³È¯ Åõ¼®±â
  • ÇÕ¼º ¼¶À¯¸· Åõ¼®±â

Á¦8Àå Åõ¼®±â ½ÃÀå : Çѿܿ©°ú °è¼öº°

  • ¼­·Ð
  • ÇÏÀ̽º·çDz(High throughput)°ú °íÈ¿À² Åõ¼®±â
  • ÀúÇѿܿ©°ú °è¼ö Åõ¼®±â

Á¦9Àå Åõ¼®±â ½ÃÀå : ±¸¼ºº°

  • ¼­·Ð
  • Ç÷§ À¯Çü
  • Áß°ø»ç À¯Çü
  • Æ©ºê À¯Çü

Á¦10Àå Åõ¼®±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼­·Ð
  • ÀçÅà Åõ¼®
  • ¼¾Åͳ»

Á¦11Àå ¾Æ¸Þ¸®Ä«ÀÇ Åõ¼®±â ½ÃÀå

  • ¼­·Ð
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Åõ¼®±â ½ÃÀå

  • ¼­·Ð
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦13Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« Åõ¼®±â ½ÃÀå

  • ¼­·Ð
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦14Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®

±â¾÷ ¸®½ºÆ®

  • Medica Trading LLC
  • Fresenius Medical Care AG & Co. KGaA
  • Lepu Medical Technology(Beijing) Co.,Ltd.
  • Allmed Medical Care Holdings Limited
  • Shandong Weigao Group Medical Polymer Company Limited
  • Advin Health Care
  • AWAK Technologies
  • B. Braun SE
  • Cantel Medical Corporation
  • Nikkiso Co., Ltd.
  • Baxter International, Inc.
  • Poly Medicure Ltd.
  • Nipro Corporation
  • Farmasol Medical Products Ind. and Trd. Co.
  • Dialife SA
  • Sb-Kawasumi Laboratories, Inc.
  • Toray Industries, Inc.
  • Asahi Kasei Corporation
  • Browndove Healthcare Pvt. Ltd.
  • Medtronic PLC
  • Bain Medical Equipment(Guangzhou) Co., Ltd
KSA 24.12.06

The Dialyzer Market was valued at USD 11.98 billion in 2023, expected to reach USD 12.65 billion in 2024, and is projected to grow at a CAGR of 5.66%, to USD 17.62 billion by 2030.

The dialyzer market comprises devices used in hemodialysis, a process that removes waste and excess water from the blood, primarily for patients suffering from renal failure. The necessity of dialyzers in the medical landscape arises as they serve a critical role in kidney disease management. This medical device finds primary application in hospitals and clinics, with end-users spanning across private treatment centers and homecare settings, given the burgeoning need for convenient healthcare solutions. Market growth is significantly influenced by the increasing prevalence of chronic kidney disorders, rising diabetes and hypertension cases, and technological advancements in dialysis equipment, which promise enhanced patient comfort and treatment efficacy. This advancement has also uncovered potential opportunities, particularly in portable and home-based dialysis systems, which are gaining traction due to growing patient preference for at-home care. However, market limitations include high treatment costs, stringent regulatory frameworks, and the dependency on healthcare reimbursement policies, which may deter growth in certain regions. Increased research effort is poised towards biocompatible materials and miniaturized dialyzer technology, which could spur innovation in developing more efficient, patient-friendly products while addressing existing treatment limitations such as vascular access complications and dialysis-related infections. The nature of the market is competitive, with prominent players continuously striving for technological refinement, which urges the need for companies to focus on affordable model innovation and strategic partnerships to broaden market reach. Encouraging personalized dialysis treatment methods, like tailored dialyzer membranes for specific patient groups, remains an area of burgeoning research and development. Businesses looking to innovate and expand should focus on enhancing product accessibility, leveraging artificial intelligence for treatment optimization, and exploring emerging markets with unmet hemodialysis needs, capitalizing on the confluence of healthcare infrastructure development and increasing renal disease burdens globally.

KEY MARKET STATISTICS
Base Year [2023] USD 11.98 billion
Estimated Year [2024] USD 12.65 billion
Forecast Year [2030] USD 17.62 billion
CAGR (%) 5.66%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dialyzer Market

The Dialyzer Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of Diabetes and Hypertension Along with Shortage of Kidneys Transplantation
    • Increasing Geriatric Population Combined with Age-Related Kidney Diseases
    • Growth in Funding for Dialysis Products Improvement & Development
  • Market Restraints
    • Complications and Risks Associated with the Procedure of Hemodialysis
  • Market Opportunities
    • Growing New Developments and Product Approvals Leading to Better Adoption
    • Rising Preference of In-Home Hemodialysis and Potential in Wearables & Portable Dialysis Devices
  • Market Challenges
    • Rising Patient Pool Opting for Alternative Kidney Procedures

Porter's Five Forces: A Strategic Tool for Navigating the Dialyzer Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dialyzer Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dialyzer Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dialyzer Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dialyzer Market

A detailed market share analysis in the Dialyzer Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dialyzer Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dialyzer Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Dialyzer Market, highlighting leading vendors and their innovative profiles. These include Medica Trading LLC, Fresenius Medical Care AG & Co. KGaA, Lepu Medical Technology(Beijing)Co.,Ltd., Allmed Medical Care Holdings Limited, Shandong Weigao Group Medical Polymer Company Limited, Advin Health Care, AWAK Technologies, B. Braun SE, Cantel Medical Corporation, Nikkiso Co., Ltd., Baxter International, Inc., Poly Medicure Ltd., Nipro Corporation, Farmasol Medical Products Ind. and Trd. Co., Dialife SA, Sb-Kawasumi Laboratories, Inc., Toray Industries, Inc., Asahi Kasei Corporation, Browndove Healthcare Pvt. Ltd., Medtronic PLC, and Bain Medical Equipment (Guangzhou) Co., Ltd.

Market Segmentation & Coverage

This research report categorizes the Dialyzer Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across High-flux Dialyzer, Low-flux Dialyzer, and Protein-leaking Membrane Dialyzers.
  • Based on Membrane Material, market is studied across Acetate Cellulose Membrane Dialyzer, Regenerated Cellulose Membrane Dialyzer, Replace Fiber Membrane Dialyzer, and Synthetic Fiber Membrane Dialyzer.
  • Based on Ultrafiltration Coefficient, market is studied across High-throughput & high-efficiency Dialyzer and Low Ultrafiltration Coefficient Dialyzer.
  • Based on Configuration, market is studied across Flat Type, Hollow Fiber Type, and Tube Type.
  • Based on End-User, market is studied across Home Dialysis and In-center.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of Diabetes and Hypertension Along with Shortage of Kidneys Transplantation
      • 5.1.1.2. Increasing Geriatric Population Combined with Age-Related Kidney Diseases
      • 5.1.1.3. Growth in Funding for Dialysis Products Improvement & Development
    • 5.1.2. Restraints
      • 5.1.2.1. Complications and Risks Associated with the Procedure of Hemodialysis
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing New Developments and Product Approvals Leading to Better Adoption
      • 5.1.3.2. Rising Preference of In-Home Hemodialysis and Potential in Wearables & Portable Dialysis Devices
    • 5.1.4. Challenges
      • 5.1.4.1. Rising Patient Pool Opting for Alternative Kidney Procedures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing preference for High-flux dialyzers due to high efficiency
    • 5.2.2. Membrane Material: Advancements in regenerated cellulose membranes for better biocompatibility
    • 5.2.3. Ultrafiltration Coefficient: Need based preference for low ultrafiltration coefficient dialyzer
    • 5.2.4. Configuration: Rising utilization of Flat-type dialyzers for gentle dialysis in renal disease conditions
    • 5.2.5. End-User: Diverse applications in home dialysis facilities for increased comfort
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Dialyzer Market, by Type

  • 6.1. Introduction
  • 6.2. High-flux Dialyzer
  • 6.3. Low-flux Dialyzer
  • 6.4. Protein-leaking Membrane Dialyzers

7. Dialyzer Market, by Membrane Material

  • 7.1. Introduction
  • 7.2. Acetate Cellulose Membrane Dialyzer
  • 7.3. Regenerated Cellulose Membrane Dialyzer
  • 7.4. Replace Fiber Membrane Dialyzer
  • 7.5. Synthetic Fiber Membrane Dialyzer

8. Dialyzer Market, by Ultrafiltration Coefficient

  • 8.1. Introduction
  • 8.2. High-throughput & high-efficiency Dialyzer
  • 8.3. Low Ultrafiltration Coefficient Dialyzer

9. Dialyzer Market, by Configuration

  • 9.1. Introduction
  • 9.2. Flat Type
  • 9.3. Hollow Fiber Type
  • 9.4. Tube Type

10. Dialyzer Market, by End-User

  • 10.1. Introduction
  • 10.2. Home Dialysis
  • 10.3. In-center

11. Americas Dialyzer Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Dialyzer Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Dialyzer Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Quanta Seeks FDA Approval for Revolutionary Home Dialysis Machine
    • 14.3.2. Awak Technologies and Singapore General Hospital Initiates Clinical Trial for Wearable Dialysis Device
    • 14.3.3. Poly Medicure Spearheads 'Make in India' Initiative with Breakthrough Dialysis Machine Launch

Companies Mentioned

  • 1. Medica Trading LLC
  • 2. Fresenius Medical Care AG & Co. KGaA
  • 3. Lepu Medical Technology(Beijing)Co.,Ltd.
  • 4. Allmed Medical Care Holdings Limited
  • 5. Shandong Weigao Group Medical Polymer Company Limited
  • 6. Advin Health Care
  • 7. AWAK Technologies
  • 8. B. Braun SE
  • 9. Cantel Medical Corporation
  • 10. Nikkiso Co., Ltd.
  • 11. Baxter International, Inc.
  • 12. Poly Medicure Ltd.
  • 13. Nipro Corporation
  • 14. Farmasol Medical Products Ind. and Trd. Co.
  • 15. Dialife SA
  • 16. Sb-Kawasumi Laboratories, Inc.
  • 17. Toray Industries, Inc.
  • 18. Asahi Kasei Corporation
  • 19. Browndove Healthcare Pvt. Ltd.
  • 20. Medtronic PLC
  • 21. Bain Medical Equipment (Guangzhou) Co., Ltd
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦